Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Svetlana G. Frolova"'
Publikováno v:
RUDN Journal of Ecology and Life Safety, Vol 32, Iss 1, Pp 41-50 (2024)
According to the World Health Organization (WHO), antibiotic resistance is currently one of the most serious threats to human health, food security, and development. Tuberculosis (TB) remains one of the deadliest bacterial diseases. The primary chall
Externí odkaz:
https://doaj.org/article/e688a719bfe545b3bc0d9bf3a85187a3
Autor:
Svetlana G. Frolova, Aleksey A. Vatlin, Dmitry A. Maslov, Buhari Yusuf, Galina I. Buravchenko, Olga B. Bekker, Ksenia M. Klimina, Svetlana V. Smirnova, Lidia M. Shnakhova, Irina K. Malyants, Arseniy I. Lashkin, Xirong Tian, Md Shah Alam, George V. Zatonsky, Tianyu Zhang, Andrey E. Shchekotikhin, Valery N. Danilenko
Publikováno v:
Pharmaceuticals, Vol 16, Iss 11, p 1565 (2023)
The World Health Organization (WHO) reports that tuberculosis (TB) is one of the top 10 leading causes of global mortality. The increasing incidence of multidrug-resistant TB highlights the urgent need for an intensified quest to discover innovative
Externí odkaz:
https://doaj.org/article/7b6df8ca6f984542aff888c5ab626b96
Transcriptomic dataset of Mycolicibacterium smegmatis exposed to an imidazo[1,2-b][1,2,4,5]tetrazine
Autor:
Aleksey A. Vatlin, Ksenia M. Klimina, Svetlana G. Frolova, Valery N. Danilenko, Dmitry A. Maslov
Publikováno v:
Data in Brief, Vol 31, Iss , Pp 105805- (2020)
Deciphering the mechanism of action of novel anti-tuberculosis compounds is a key step in the drug development process. We have previously described a number of imidazo[1,2-b][1,2,4,5]tetrazines with a promising activity on Mycobacterium tuberculosis
Externí odkaz:
https://doaj.org/article/2125443dc5854ea8a7b3a174aa267682
Autor:
Galina I. Buravchenko, Dmitry A. Maslov, Md Shah Alam, Natalia E. Grammatikova, Svetlana G. Frolova, Aleksey A. Vatlin, Xirong Tian, Ivan V. Ivanov, Olga B. Bekker, Maxim A. Kryakvin, Olga A. Dontsova, Valery N. Danilenko, Tianyu Zhang, Andrey E. Shchekotikhin
Publikováno v:
Pharmaceuticals, Vol 15, Iss 2, p 155 (2022)
The emergence of drug resistance in pathogens leads to a loss of effectiveness of antimicrobials and complicates the treatment of bacterial infections. Quinoxaline 1,4-dioxides represent a prospective scaffold for search of new compounds with improve
Externí odkaz:
https://doaj.org/article/17ea61f5138d44bb89a59f1d3a20aa96
Autor:
Svetlana G. Frolova, Ksenia M. Klimina, Ravinder Kumar, Aleksey A. Vatlin, Deepak B. Salunke, Pravin Kendrekar, Valery N. Danilenko, Dmitry A. Maslov
Publikováno v:
Antibiotics, Vol 10, Iss 1, p 6 (2020)
Tuberculosis (TB), caused by Mycobacterium tuberculosis, is a global burden, responsible for over 1 million deaths annually. The emergence and spread of drug-resistant M. tuberculosis strains (MDR-, XDR- and TDR-TB) is the main challenge in global TB
Externí odkaz:
https://doaj.org/article/eba55414ef7d4fe08d6edc68f9a37f3e
Autor:
Galina I. Buravchenko, Dmitry A. Maslov, Md Shah Alam, Natalia E. Grammatikova, Svetlana G. Frolova, Aleksey A. Vatlin, Xirong Tian, Ivan V. Ivanov, Olga B. Bekker, Maxim A. Kryakvin, Olga A. Dontsova, Valery N. Danilenko, Tianyu Zhang, Andrey E. Shchekotikhin
Publikováno v:
Pharmaceuticals; Volume 15; Issue 2; Pages: 155
The emergence of drug resistance in pathogens leads to a loss of effectiveness of antimicrobials and complicates the treatment of bacterial infections. Quinoxaline 1,4-dioxides represent a prospective scaffold for search of new compounds with improve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bb42729a4f865b5b909d4516b7866c2
https://pubmed.ncbi.nlm.nih.gov/35215268
https://pubmed.ncbi.nlm.nih.gov/35215268